Significance of the serum lithium concentration and the treatment regimen for wanted and unwanted effects of lithium treatment

  • Mogens Schou

Abstract

Lithium (Li) treatment was the first psychiatric therapy to be monitored through determination of serum concentrations of the drug. In the beginning this served to guard against overdosage and poisoning, but later it was used to ensure sufficient levels for achievement of effect. When Li started being used for prophylactic purposes, i.e. for prevention or alleviation of manic-depressive recurrences, the monitoring procedure became particularly important, because under these circumstances no symptoms were present, and dosage adjustment could therefore not be based on clinical assessment.

Keywords

Toxicity Lithium Creatinine Arginine Vasopressin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amdisen, A. (1980). Monitoring lithium dose levels: clinical aspects of serum lithium estimation. In Handbook of Lithium Therapy (ed. F.N. Johnson), MTP Press, Lancaster, pp. 196–9CrossRefGoogle Scholar
  2. Baastrup, P.C. (1980). Lithium in the prophylactic treatment of recurrent affective disorders. In Handbook of Lithium Therapy (ed. F.N. Johnson), MTP Press, Lancaster, pp. 26–38CrossRefGoogle Scholar
  3. Hullin, R.P. (1981). Relationships between plasma lithium levels and clinical and biological responses. In Recent Advances in Neuropsychopharmacology (ed. B. Angrist et al.), Pergamon, New York, pp. 373–82CrossRefGoogle Scholar
  4. Hullin, R.P., Coley, V.P., Birch, N.J., Thomas, T.H. and Morgan, D.B. (1979). Renal function after long-term treatment with lithium. Br. Med. J., 2, 1457–9CrossRefGoogle Scholar
  5. Lauritsen, B.J., Mellerup, E.T., Plenge, P., Rasmussen, S., Vestergaard, P. and Schou, M. (1981). Serum lithium concentrations around the clock with different treatment regimens and the diurnal variation of the renal lithium clearance. Acta Psychiat. Scand., 64, 314–19CrossRefPubMedGoogle Scholar
  6. Penney, M.D., Hullin, R.P., Srinivasan, D.P. and Morgan, D.B. (1981). The relationship between plasma lithium and the renal responsiveness to arginine vasopressin in man. Clin. Sci., 61, 793–5CrossRefPubMedGoogle Scholar
  7. Sarantidis, D. and Waters, B. (1981). Predictors of lithium prophylaxis effectiveness. Progr. Neuro-Psychopharmacol., 5, 507–11CrossRefGoogle Scholar
  8. Sashidharan, S.P., McGuire, R.J. and Glen, A.I.M. (1982). Plasma lithium levels and therapeutic outcome in the prophylaxis of affective disorders: a retrospective study. Br. J. Psychiatry, 140, 619–22CrossRefPubMedGoogle Scholar
  9. Schou, M., Amdisen, A., Thomsen, K., Vestergaard, P., Hetmar, O., Mellerup, E.T., Plenge, P. and Rafaelsen, O.J. (1982). Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology, 77, 387–90CrossRefPubMedGoogle Scholar
  10. Thomsen, K. (1978). Renal handling of lithium at non-toxic and toxic serum lithium levels: a review. Dan. Med. Bull., 25, 106–15PubMedGoogle Scholar
  11. Thomsen, K., Holstein-Rathlou, N.-H. and Leyssac, P.O. (1981). Comparison of three measures of proximal tubular reabsorption: lithium clearance, occlusion time, and micropuncture. Am. J. Physiol., 241, F348–55Google Scholar
  12. Vestergaard, P. and Amdisen, A. (1981). Lithium treatment and kidney function: a follow-up study of 237 patients in longterm treatment. Acta Psychiat. Scand., 63, 333–45CrossRefPubMedGoogle Scholar
  13. Vestergaard, P. and Thomsen, K. (1981). Renal side effects of lithium: the importance of the serum lithium level. Psychopharmacology, 72, 203–4CrossRefPubMedGoogle Scholar

Copyright information

© The contributors 1983

Authors and Affiliations

  • Mogens Schou
    • 1
  1. 1.The Psychopharmacology Research UnitAarhus University Institute of Psychiatry and the Psychiatric HospitalRisskovDenmark

Personalised recommendations